This is the authors' abstract. We don't add key points for this paper.
Objectives This study investigated the association between nirmatrelvir plus ritonavir (NMV-r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 during Omicron XBB subvariants.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: